株式会社CLINICAL STUDY SUPPORT
Japan
〒461-0005 名古屋市東区東桜1-10-9 栄プラザビル2F
Company name
Group
Parent
Subsidiary
Customer
Supplier
Alliance
Bank
Shareholder
Loading...
Loading the relationship graph...
16 entries
| Date | Description |
|---|
| 2004-04 |
Clinical Study Support, Ltd. opened the first office in Kuwana, Japan. |
| 2004-04 |
三重県桑名市にて、有限会社CLINICAL STUDY SUPPORT 事業開始 |
| 2006-06 |
Clinical Study Support, Ltd. changed its trade name to Clinical Study Support, Inc. (CSS) and relocated to Chikusa, Nagoya, Japan. |
| 2006-06 |
株式会社に商号変更、名古屋市千種区（名古屋医工連携インキュベータ）に本店移転 |
| 2006-09 |
CSS signed a joint venture partnership with Shin Nippon Biomedical Laboratories, Ltd. The capital was increased to 53.4 million JPY. |
| 2006-09 |
株式会社新日本科学と合弁事業契約を締結、資本金5,340万円に増資 |
| 2015-05 |
Corporate headquarters was relocated to the current address (Naka-ku, Nagoya, Japan). |
| 2015-05 |
名古屋市中区に本店移転 |
| 2018-01 |
CSS transferred its SMO business to Shin Nippon Biomedical Laboratories SMO, Ltd. |
| 2018-01 |
SMO事業を株式会社新日本科学ＳＭＯに事業譲渡 |
| 2022-11 |
Tatsuya Isomura appointed as Founder Director and CVO. : Norimasa Kikuchi (Co-Founder) appointed as President and CEO. |
| 2022-11 |
磯村達也 創業者取締役 CVOに就任 : 菊池徳昌（共同創業者） 代表取締役社長 CEOに就任 |
| 2023-12 |
Ken Takanashi appointed as Chairman and President and CEO. |
| 2023-12 |
高梨 健 代表取締役会長兼社長 CEOに就任 |
| 2024-02 |
Corporate headquarters was relocated to the current address (Higashi-ku, Nagoya, Japan). |
| 2024-02 |
名古屋市東区に本店移転 |
2026-09-21 18:02 (Model: gpt-oss-20b(99) )
